Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 225

1.

Relation of carbohydrate antigen-125 to left atrial remodeling and its prognostic usefulness in patients with heart failure and preserved left ventricular ejection fraction in women.

Hung CL, Hung TC, Liu CC, Wu YJ, Kuo JY, Hou CJ, Yeh HI.

Am J Cardiol. 2012 Oct 1;110(7):993-1000. doi: 10.1016/j.amjcard.2012.05.030. Epub 2012 Jun 22.

PMID:
22728006
2.

Growth differentiation factor 15, ST2, high-sensitivity troponin T, and N-terminal pro brain natriuretic peptide in heart failure with preserved vs. reduced ejection fraction.

Santhanakrishnan R, Chong JP, Ng TP, Ling LH, Sim D, Leong KT, Yeo PS, Ong HY, Jaufeerally F, Wong R, Chai P, Low AF, Richards AM, Lam CS.

Eur J Heart Fail. 2012 Dec;14(12):1338-47. doi: 10.1093/eurjhf/hfs130. Epub 2012 Aug 5.

3.

Prognostic value of baseline plasma amino-terminal pro-brain natriuretic peptide and its interactions with irbesartan treatment effects in patients with heart failure and preserved ejection fraction: findings from the I-PRESERVE trial.

Anand IS, Rector TS, Cleland JG, Kuskowski M, McKelvie RS, Persson H, McMurray JJ, Zile MR, Komajda M, Massie BM, Carson PE.

Circ Heart Fail. 2011 Sep;4(5):569-77. doi: 10.1161/CIRCHEARTFAILURE.111.962654. Epub 2011 Jun 29.

4.

Usefulness of N-terminal pro-brain natriuretic Peptide and brain natriuretic peptide to predict cardiovascular outcomes in patients with heart failure and preserved left ventricular ejection fraction.

Grewal J, McKelvie RS, Persson H, Tait P, Carlsson J, Swedberg K, Ostergren J, Lonn E.

Am J Cardiol. 2008 Sep 15;102(6):733-7. doi: 10.1016/j.amjcard.2008.04.048. Epub 2008 Jul 9.

PMID:
18773998
5.

Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in predicting survival in patients with chronic heart failure.

von Haehling S, Jankowska EA, Morgenthaler NG, Vassanelli C, Zanolla L, Rozentryt P, Filippatos GS, Doehner W, Koehler F, Papassotiriou J, Kremastinos DT, Banasiak W, Struck J, Ponikowski P, Bergmann A, Anker SD.

J Am Coll Cardiol. 2007 Nov 13;50(20):1973-80. Epub 2007 Oct 29.

6.

Impaired systolic function by strain imaging in heart failure with preserved ejection fraction.

Kraigher-Krainer E, Shah AM, Gupta DK, Santos A, Claggett B, Pieske B, Zile MR, Voors AA, Lefkowitz MP, Packer M, McMurray JJ, Solomon SD; PARAMOUNT Investigators.

J Am Coll Cardiol. 2014 Feb 11;63(5):447-56. doi: 10.1016/j.jacc.2013.09.052. Epub 2013 Oct 30. Erratum in: J Am Coll Cardiol. 2014 Jul 22;64(3):335.

7.

Growth differentiation factor-15 is a useful prognostic marker in patients with heart failure with preserved ejection fraction.

Izumiya Y, Hanatani S, Kimura Y, Takashio S, Yamamoto E, Kusaka H, Tokitsu T, Rokutanda T, Araki S, Tsujita K, Tanaka T, Yamamuro M, Kojima S, Tayama S, Kaikita K, Hokimoto S, Ogawa H.

Can J Cardiol. 2014 Mar;30(3):338-44. doi: 10.1016/j.cjca.2013.12.010. Epub 2013 Dec 18.

PMID:
24484911
8.

Differences in biomarkers in patients with heart failure with a reduced vs a preserved left ventricular ejection fraction.

de Denus S, Lavoie J, Ducharme A, O'Meara E, Racine N, Sirois MG, Neagoe PE, Zhu L, Rouleau JL, White M.

Can J Cardiol. 2012 Jan-Feb;28(1):62-8. doi: 10.1016/j.cjca.2011.09.007. Epub 2011 Nov 21.

PMID:
22104539
9.

Prognostic value of cystatin C on admission in heart failure with preserved ejection fraction.

Carrasco-Sánchez FJ, Galisteo-Almeda L, Páez-Rubio I, Martínez-Marcos FJ, Camacho-Vázquez C, Ruiz-Frutos C, Pujol-De La Llave E.

J Card Fail. 2011 Jan;17(1):31-8. doi: 10.1016/j.cardfail.2010.07.248.

PMID:
21187262
10.

Left atrial function predicts heart failure hospitalization in subjects with preserved ejection fraction and coronary heart disease: longitudinal data from the Heart and Soul Study.

Welles CC, Ku IA, Kwan DM, Whooley MA, Schiller NB, Turakhia MP.

J Am Coll Cardiol. 2012 Feb 14;59(7):673-80. doi: 10.1016/j.jacc.2011.11.012.

11.

Clinical and prognostic effects of atrial fibrillation in heart failure patients with reduced and preserved left ventricular ejection fraction.

Linssen GC, Rienstra M, Jaarsma T, Voors AA, van Gelder IC, Hillege HL, van Veldhuisen DJ.

Eur J Heart Fail. 2011 Oct;13(10):1111-20. doi: 10.1093/eurjhf/hfr066. Epub 2011 Jun 3.

12.

Baseline plasma NT-proBNP and clinical characteristics: results from the irbesartan in heart failure with preserved ejection fraction trial.

McKelvie RS, Komajda M, McMurray J, Zile M, Ptaszynska A, Donovan M, Carson P, Massie BM; I-Preserve Investigators.

J Card Fail. 2010 Feb;16(2):128-34. doi: 10.1016/j.cardfail.2009.09.007. Epub 2009 Nov 4.

PMID:
20142024
13.

Plasma N-terminal protype-B natriuretic peptide and restrictive mitral flow to risk-stratify patients with stage B heart failure.

Dini FL, Whalley G, Poppe K, Fontanive P, Rosa GM, Doughty RN, Di Bello V.

Clin Cardiol. 2009 Dec;32(12):711-7. doi: 10.1002/clc.20617.

14.

Prevalence and prognosis of heart failure with preserved ejection fraction and elevated N-terminal pro brain natriuretic peptide: a 10-year analysis from the Copenhagen Hospital Heart Failure Study.

Carlsen CM, Bay M, Kirk V, Gøtze JP, Køber L, Nielsen OW.

Eur J Heart Fail. 2012 Mar;14(3):240-7. doi: 10.1093/eurjhf/hfs003. Epub 2012 Feb 7.

15.

Left atrial remodeling and function in advanced heart failure with preserved or reduced ejection fraction.

Melenovsky V, Hwang SJ, Redfield MM, Zakeri R, Lin G, Borlaug BA.

Circ Heart Fail. 2015 Mar;8(2):295-303. doi: 10.1161/CIRCHEARTFAILURE.114.001667. Epub 2015 Jan 15.

16.

Associations between neurohormonal and inflammatory activation and heart failure in children.

Ratnasamy C, Kinnamon DD, Lipshultz SE, Rusconi P.

Am Heart J. 2008 Mar;155(3):527-33. doi: 10.1016/j.ahj.2007.11.001.

PMID:
18294492
18.
19.

Comparison of usefulness of echocardiographic Doppler variables to left ventricular end-diastolic pressure in predicting future heart failure events.

Liang HY, Cauduro SA, Pellikka PA, Bailey KR, Grossardt BR, Yang EH, Rihal C, Seward JB, Miller FA, Abraham TP.

Am J Cardiol. 2006 Mar 15;97(6):866-71. Epub 2006 Jan 30.

PMID:
16516591
20.

Usefulness of tissue Doppler imaging-myocardial performance index in the evaluation of diastolic dysfunction and heart failure with preserved ejection fraction.

Kim H, Yoon HJ, Park HS, Cho YK, Nam CW, Hur SH, Kim YN, Kim KB.

Clin Cardiol. 2011 Aug;34(8):494-9. doi: 10.1002/clc.20932. Epub 2011 Jul 20.

Items per page

Supplemental Content

Write to the Help Desk